Pluri Inc. (PLUR)
NASDAQ: PLUR · Real-Time Price · USD
4.330
-0.340 (-7.28%)
Feb 21, 2025, 4:00 PM EST - Market closed
Pluri Employees
As of June 30, 2024, Pluri had 118 total employees, including 106 full-time and 12 part-time employees. The number of employees decreased by 16 or -11.94% compared to the previous year.
Employees
118
Change (1Y)
-16
Growth (1Y)
-11.94%
Revenue / Employee
$5,746
Profits / Employee
-$168,305
Market Cap
30.30M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
PLUR News
- 4 days ago - Ever After Foods and Bühler Collaborate to Scale Cultivated Meat Production and Distribution - GlobeNewsWire
- 4 weeks ago - Pluri Secures $6.5 Million Strategic Investment at Premium to Market, Enters Cacao Market Through Acquisition - GlobeNewsWire
- 2 months ago - Pluri Congratulates Mesoblast on FDA Approval of First Mesenchymal Stromal Cell Therapy for Steroid-Refractory Acute Graft-Versus-Host Disease - GlobeNewsWire
- 3 months ago - Pluri Inc. to Present at November 21st Virtual Investor Summit Microcap Event - Accesswire
- 3 months ago - BrainStorm Cell Therapeutics and Pluri Partner to Support NurOwn® Phase 3b Trial Manufacturing - PRNewsWire
- 7 months ago - Pluri's CDMO Selected to Manufacture Kadimastem's Novel Cell Therapy Product Candidates - GlobeNewsWire
- 8 months ago - Pluri: Biotech Play With Several Opportunities Across Different Sectors - Seeking Alpha
- 8 months ago - Pluri Subsidiary Ever After Foods Secured $10 Million Strategic Investment to Solve Cultivated Food Scalability Challenges - GlobeNewsWire